Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores

  title={Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores},
  author={S Y Zhuang and Daniel Bridges and Elena V. Grigorenko and S Mccloud and Andrew Boon and Robert E. Hampson and Sam A. Deadwyler},

Figures from this paper

Signaling pathways from CB1 receptor activation to inhibition of NMDA-mediated calcium influx and neurotoxicity in dorsal root ganglion neurons

The data suggest that WIN-induced [Ca 2+ ] i rise is required for WIN to protect cells from NMDA-induced cytotoxicity, and suggests that release intracellular stores by receptor prevents the cannabinoid from inhibiting the calcium influx related to the excitotoxicity of neurons and development of neuropathic pain.

Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate.

Cannabinoids require the HINT1 protein to counteract the toxic effects of NMDAR-mediated NO production and zinc release, and situates the Hint1 protein at the forefront of cannabinoid protection against NMDar-mediated brain damage.

Activation of ryanodine receptors is required for PKA‐mediated downregulation of A‐type K+ channels in rat hippocampal neurons

A possibility that RyR contribution and mediated IA downregulation are required to regulate membrane excitability as well as synaptic plasticity in CA3‐CA1 connections of the hippocampus is suggested.

ffects of endogenous cannabinoid anandamide on xcitation – contraction coupling in rat ventricular myocytes

The results suggest that AEA depresses ventricular myocyte contractility by decreasing the action potential duration (APD) in a B1 an manner independent of C.

IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei.

Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum

Results show that the state of activation of A2 ARs regulates the synaptic effects of CB1Rs and that A2ARs may control CB1 effects also indirectly, namely through mGlu5Rs.



Cannabinoids Enhance NMDA-Elicited Ca2+ Signals in Cerebellar Granule Neurons in Culture

A novel action of cannabinoids to enhance intracellular Ca2+responses in CNS neurons is identified and it is suggested that the CNS cannabinoid system could serve a critical modulatory role in CNS neuron through the regulation of intrACEllular Ca 2+signaling.

Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures

Cannabinoids may have therapeutic potential in disorders resulting from cerebral ischemia, including stroke, and may protect neurons from injury through a variety of mechanisms, including receptor-mediated neuroprotection.

Cannabinoid and kappa opioid receptors reduce potassium K current via activation of G(s) proteins in cultured hippocampal neurons.

The results indicate that CB1 and kappa receptor activation is additive with respect to I(K) amplitude, suggesting that CB 1 andkappa receptors share a common G(s) protein signaling pathway involving PKC.

Cannabinoids modulate potassium current in cultured hippocampal neurons.

Data support the conclusion that cannabinoid effects on IA are mediated through G-protein-coupled receptors, and a cannabinoid-induced shift in the voltage dependence of IA could serve to counteract fast, transient, depolarizing events such as action potentials and synaptic currents in hippocampal neurons.

Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.

The results suggest a major role for cannabinoids (endogenous and exogenous) in the modulation of synaptic transmission at CNS synapses, and demonstrate cannabinoid-receptor-mediated inhibition of distinct Ca2+ channels in central neurons.

Cannabinoid receptors differentially modulate potassium A and D currents in hippocampal neurons in culture.

The differential effects of cannabinoids on I(A) and I(D) were both shown to be mediated via the well documented cannabinoid receptor inhibition of adenylyl cyclase and subsequent modulation of cAMP and protein kinase.

Mechanisms of Cannabinoid Inhibition of GABAASynaptic Transmission in the Hippocampus

Recordings of whole-cell voltage-clamp recordings suggest that presynaptic CB1 receptors reduce GABAA- but not GABAB-mediated synaptic inhibition of CA1 pyramidal neurons by inhibiting VDCCs located on inhibitory nerve terminals.

Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process.

The results confirmed that pertussis toxin-sensitive cannabinoid receptor-mediated changes in IA were probably the result of inhibition of adenylate cyclase, and modulation of IA conductance properties via cannabinoid receptors-mediated inhibition of cAMP levels within the cell is discussed.

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.

Cannabidiol was more protective against glutamate neurotoxicity than either ascorbate or alpha-tocopherol, indicating it to be a potent antioxidant, and data suggest that the naturally occurring, nonpsychotropic cannabinoid, cannABidiol, may be a potentially useful therapeutic agent for the treatment of oxidative neurological disorders such as cerebral ischemia.

Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.

A mechanism by which endocannibinoids might influence presynaptic function is suggested by whether endocannabinoids inhibit N-type voltage-dependent Ca2+ channels by activating G(i/o)-protein-coupled CB1 cannabinoid receptors (CB1R)--a possible mechanism underlying DSI/DSE.